Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Sleep
|
May 29, 2023
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
Yves Dauvilliers, Thomas Roth, Richard Bogan, et al.
CNS Drugs
|
April 5, 2022
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
Thomas Roth, Yves Dauvilliers, Michael J Thorpy, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease
Jeffrey F Waring, Qi Tang, Weining Z Robieson, et al.
Clinical and Translational Gastroenterology
|
April 1, 2016
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
Michael Epstein, David A Johnson, Robert Hawes, et al.
Eclinicalmedicine
|
October 29, 2024
CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial
Nicola L Brice, Mark Carlton, David H Margolin, et al.
Sleep
|
August 6, 2021
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
Clete A Kushida, Colin M Shapiro, Thomas Roth, et al.
Headache
|
September 1, 2006
The relation of brain ouabain-like compounds and idiopathic intracranial hypertension
Mark Borsody, Irene Semenov, Kathleen Carroll, et al.
Neurology and Therapy
|
June 15, 2025
Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson's Disease
Gil L'Italien, Basia Rogula, Lauren Powell, et al.
Parkinsonism & Related Disorders
|
October 17, 2025
Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting
Gil L'Italien, Basia Rogula, Lauren C Powell, et al.
Stroke (Hoboken, N.J.)
|
May 6, 2026
RNS60 RESCUE Trial in Acute Ischemic Stroke: Post Hoc Analysis in Participants Enrolled <12 Hours Since Last Known Well
Supurna Ghosh, Jordan Dubow, Christopher G Favilla, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Sleep
|
May 29, 2023
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
Yves Dauvilliers, Thomas Roth, Richard Bogan, et al.
CNS Drugs
|
April 5, 2022
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
Thomas Roth, Yves Dauvilliers, Michael J Thorpy, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease
Jeffrey F Waring, Qi Tang, Weining Z Robieson, et al.
Clinical and Translational Gastroenterology
|
April 1, 2016
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
Michael Epstein, David A Johnson, Robert Hawes, et al.
Eclinicalmedicine
|
October 29, 2024
CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial
Nicola L Brice, Mark Carlton, David H Margolin, et al.
Sleep
|
August 6, 2021
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
Clete A Kushida, Colin M Shapiro, Thomas Roth, et al.
Headache
|
September 1, 2006
The relation of brain ouabain-like compounds and idiopathic intracranial hypertension
Mark Borsody, Irene Semenov, Kathleen Carroll, et al.
Neurology and Therapy
|
June 15, 2025
Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson's Disease
Gil L'Italien, Basia Rogula, Lauren Powell, et al.
Parkinsonism & Related Disorders
|
October 17, 2025
Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting
Gil L'Italien, Basia Rogula, Lauren C Powell, et al.
Stroke (Hoboken, N.J.)
|
May 6, 2026
RNS60 RESCUE Trial in Acute Ischemic Stroke: Post Hoc Analysis in Participants Enrolled <12 Hours Since Last Known Well
Supurna Ghosh, Jordan Dubow, Christopher G Favilla, et al.
Page
of 3